This tool can be used for peer-to-peer, physician-to-patient, and physician-to-caregiver discussions, allowing you to virtually explore two important drug classes used in type 2 diabetes: SGLT2 inhibitors and GLP-1 receptor agonists. The benefits of these agents are carefully described, matched to a visually engaging depiction of their glucose-lowering mechanisms and their effects on different organ systems.
9Apps 4.9
![TYPE 2 DIABETES: NEW NICE GUIDELINES [2022] EXPLAINED screenshot 5](https://i.ytimg.com/vi/SlzcRoNWJd0/mqdefault.jpg)
